Artwork
iconShare
 
Manage episode 479539779 series 2992374
Content provided by Ellen Yin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ellen Yin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

What if making your product harder to access was the secret to increasing demand?

That’s the counterintuitive strategy sisters Olivia and Chloe Ferro bet on to catapult their startup SheMed to over 20,000 sign-ups in just a few months.

As the UK’s first female-focused GLP-1 program, SheMed entered a crowded weight-loss market—but instead of competing on convenience, they bet on credibility. By requiring mandatory blood tests before prescribing medication, they not only differentiated themselves but uncovered a staggering insight: 99% of applicants had undiagnosed health conditions.

The payoff? A 3X surge in inbound leads, a 120% increase in patient sign-ups, and high-trust partnerships with major clinics—all fueled by a safety-first approach that turned medical rigor into a viral growth lever.

If you’ve ever worried that implementing stricter client or customer qualifications might slow your sales, this case study is an excellent reminder that trust is your most powerful conversion strategy.

Thank you to our sponsor!

Connect with Chloe + Olivia:

Iconic business leaders all have their own unique genius. Take this quick 10 question quiz to uncover your specific CEO style advantage: ⁠https://cubicletoceo.co/quiz⁠

If you enjoyed today's episode, please:

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

404 episodes